A
Alliance Pharma PLC
LSE:APH
Alliance Pharma PLC
LSE:APH
Price:
38.42 GBX
9.3%
Market Closed
Updated:
May 23, 2024
Alliance Pharma PLC
Depreciation & Amortization
|
Alliance Pharma PLC
Depreciation & Amortization Peer Comparison
Comparables:
GSK
AZN
INDV
HIK
DPH
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Depreciation & Amortization
-£8.7m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-32%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Depreciation & Amortization
-£68m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Depreciation & Amortization
-$3.9B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Indivior PLC
LSE:INDV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Depreciation & Amortization
-$88m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Depreciation & Amortization
-£140.2m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
See Also
What is Alliance Pharma PLC's Depreciation & Amortization?
Depreciation & Amortization
-8.7m
GBP
-8.7m
GBP
Based on the financial report for Jun 30, 2023, Alliance Pharma PLC's Depreciation & Amortization amounts to -8.7m GBP.
What is Alliance Pharma PLC's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-32%
-32%
Over the last year, the Depreciation & Amortization growth was 9%. The average annual Depreciation & Amortization growth rates for Alliance Pharma PLC have been -34% over the past three years , and -32% over the past ten years .
You don't have any saved screeners yet
